Clinical study on polycystic ovary syndrome treated with Diane-35 and Pioglitazone.

ABSTRACT:

Objective

To observe the effects of Diane-35 and pioglitazone on endocrine, blood lipid, and blood glucose metabolism in patients with polycystic ovary syndrome (PCOS).

Methods

70 PCOS patients were selected as subjects between January 2019 and January 2020 and were randomized into two groups. The control group was provided with Diane-35 for 1 tablet/day. The patients in the observation group took additional pioglitazone twice a day. The therapeutic effect of the two schemes was analyzed by observing hormone, blood lipid, and blood glucose levels. The body mass index (BMI), waist-hip ratio (WHR), and Ferriman-Gallwey score (F-G) of the two groups of patients at different time points were compared.

Results

Compared with the control group, after pioglitazone treatment,

SUBMITTER: Cao C 

PROVIDER: S-EPMC8661247 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature